Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis.
Conformational Landscape of N-Glycosylated Peptides Detecting Autoantibodies in Multiple Sclerosis, Revealed by Hamiltonian Replica Exchange.
FDA warns about seizures linked to MS drug
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Gait variability measures reveal differences between multiple sclerosis patients and healthy controls.
Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS.
Reproductive issues in women with multiple sclerosis: ethical considerations.
UVB light attenuates the systemic immune response in CNS autoimmunity.
The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.
Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease.
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
Medical marijuana: clearing away the smoke.
Associations of CD6, TNFRSF1A, and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™ (PERSIST)
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects with Multiple Sclerosis
"Tell me what you want, what you really really want….": asking people with multiple sclerosis about enhancing their participation in physical activity.
Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats.

Pages